Friday 6 November 2026 Export RYTM’s income statement to Excel — free account

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024.

Revenue: +79.6%
EPS: +26.9%
Free cash flow: +95.4%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

112.38 7.36 +7.01%

Follow RYTM

Alert me

Market cap: $7.3B
P/E: 0.0×
Fwd P/E: −31.6×
Dividend yield: —
F-score: 6/9
Altman Z: 15.89
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	4	4	5	6	+8 more TTM periods Free account
ROE Full definition →	(167.49%)	(461.65%)	(293.04%)	(251.14%)
ROA Full definition →	(41.75%)	(51.91%)	(50.14%)	(46.29%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(73.70%)	(69.36%)	(63.37%)	(55.77%)
Average Days of Receivables Full definition →	50.86	61.47	57.47	50.17
Free Cash Flow per Share Full definition →	(1.18)	(1.54)	(1.76)	(2.42)
Free Cash Flow Full definition →	(81.79)	(105.35)	(119.51)	(157.13)
Capital Expenditures Full definition →	—	—	—	(41.45)
Other line items
Cash ROIC Full definition →	(15.65%)	(19.22%)	(20.67%)	(23.84%)
Accounts Receivable Turnover Full definition →	7.78	7.21	8.35	8.51
Accounts Payable Turnover Full definition →	2.72	1.64	1.90	1.48
Inventory Turnover Full definition →	1.24	1.07	0.96	0.88
Average Days of Payables Full definition →	118.00	223.59	195.17	261.17
Days of Inventory on Hand Full definition →	344.36	422.10	454.66	482.24
Tax Rate Full definition →	0.01	0.01	0.00	0.00
Research and Development Expense of Revenue Full definition →	64.00%	72.20%	79.24%	88.19%
Selling, General and Administrative Expense of Revenue Full definition →	90.93%	100.43%	101.05%	102.73%
Share Based Compensation of Revenue Full definition →	33.28%	36.36%	35.48%	35.21%
Interest Coverage Full definition →	(10.27)	(10.86)	(9.99)	(9.33)
Operating CF/Net income Full definition →	0.41	0.50	0.58	0.57
Depreciation/Fixed assets Full definition →	1.80	10.48	1.13	1.21
Capex/Depreciation Full definition →	0.00	0.00	0.00	(30.98)
Revenue per Share Full definition →	4.07	3.50	3.19	2.92
Operating CF per Share Full definition →	(1.18)	(1.54)	(1.76)	(1.78)
Capex per Share Full definition →	0.00	0.00	0.00	(0.64)
Capex to Sales Full definition →	0.00	0.00	0.00	0.22

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly